Zagreb, Croatia

Lidija Simicic


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Lidija Simicic in Anti-Inflammatory Research

Introduction

Lidija Simicic is a prominent inventor based in Zagreb, Croatia, recognized for her groundbreaking research in the field of pharmaceuticals. With two patents to her name, she has made significant contributions to the development of compounds aimed at alleviating inflammatory diseases.

Latest Patents

Lidija's latest patents focus on substituted furochromenes, which have shown potential as anti-inflammatory agents. The first patent, titled "Substituted furochromenes, preparation thereof and their antiinflammatory action," outlines novel compounds characterized by specific formulas. These compounds, including their tautomers and pharmaceutically acceptable salts, are designed to be used as therapeutically active agents for the prophylaxis and treatment of asthma and other inflammatory diseases. Similarly, her second patent details the "Substituted furochromene compounds of antiinflammatory action," which emphasizes their use in treating various inflammatory conditions in humans.

Career Highlights

Lidija currently works for GlaxoSmithKline Istrazivacki Centar Zagreb D.o.o., a well-known research center dedicated to innovative pharmaceutical development. Her career is marked by a strong focus on medicinal chemistry and the synthesis of novel compounds that address key health concerns.

Collaborations

In her work, Lidija collaborates with esteemed colleagues such as Mladen Mercep and Milan Mesic. These collaborations enrich her research efforts and contribute to the advancement of their shared goals in inflammation research and pharmaceutical innovation.

Conclusion

Lidija Simicic's dedication to the field of anti-inflammatory research highlights the vital role inventors play in medical advancements. With her impressive portfolio of patents and collaborative efforts, she continues to pave the way for future innovations in the pharmaceutical industry. Her work not only enhances scientific understanding but also holds the promise of improving treatments for patients suffering from asthma and other inflammatory conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…